Bin-Feng Li

Title: The Innovative Contributions of Bin-Feng Li

Introduction

Bin-Feng Li, an esteemed inventor located in Suzhou Industrial Park, China, has made significant strides in the field of synthetic methodologies. With a portfolio of 8 patents to his name, he is recognized for his innovative solutions and contributions to the pharmaceutical industry.

Latest Patents

Among his latest patents, Bin-Feng Li has developed synthetic methods for the preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate). These processes include detailed techniques for creating this complex compound, including variations as solvates or hydrates. Such innovations indicate his deep understanding of chemical processes and dedication to advancing drug development.

Career Highlights

Throughout his career, Bin-Feng Li has made a name for himself by collaborating with leading companies in the industry. He has worked at Neurocrine Biosciences, Inc. and Arno Therapeutics, Inc., where he has been instrumental in various research and development projects that focus on drug synthesis and formulation.

Collaborations

In his professional journey, Bin-Feng Li has collaborated with notable coworkers such as Kevin McGee and Shawn Branum. These partnerships have facilitated an exchange of ideas and innovations, further propelling his contributions to the field of pharmaceuticals and biotechnology.

Conclusion

Bin-Feng Li stands out as a prolific inventor whose work has the potential to significantly impact the pharmaceutical landscape. With his impressive array of patents and collaborative efforts in the industry, he continues to pave the way for advancements in synthetic methodologies.